Pexelizumab in Conjunction With Angioplasty in Acute Myocardial Infarction (APEX-AMI)
Study sponsor: Procter and Gamble
Primary completion is the date data collection ends for the main study measures, not when results are published.
Primary completion2007-05Actual
Enrollment · participants5745Actual
Source updated2023-11-18Last update listed in the registry record
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.